Insider Trading & Ownership of KKR Genetic Disorder L.P.

Location
New York, NY
Summary
The estimated value of insider holdings of KKR Genetic Disorder L.P. is at least $453,525,208 dollars as of 14 May 2025. KKR Genetic Disorder L.P. is the 10%+ Owner of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $453.53M.
Signature
See Exhibit 99.1
All Insider Reports
All Insider Reports

Notify me when KKR Genetic Disorder L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of KKR Genetic Disorder L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BBIO BridgeBio Pharma, Inc. 10%+ Owner $453,525,208 -$402,960,000 -47% 12 May 2025

Insider Transactions Reported by KKR Genetic Disorder L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.